Through a series of systematic in vitro and in vivo studies, we demonstrate that NAF1 is a functional oncogene, and there may form positive feedback loops between NAF1 and numerous key molecules associated with malignant progression of gliomas via the regulation of ribosome biosynthesis. The gene discussed is NAF1; the disease is glioma.